InsiderFlow

David Krempa

ETON

David Krempa serves as officer: Chief Business Officer at Eton Pharmaceuticals, Inc. (ETON). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$5.50M

Net Position

Net Seller

$5.50M

Companies Traded

1

ETON

Active Period

Jun 2025 – Aug 2026

5 total trades

Most Recent

Sell ETON

Aug 24, 2026 · $1.63M

David Krempa's Insider Trading at Eton Pharmaceuticals, Inc. (ETON)

Buys

0 · $0.00

Sells

5 · $5.50M

Total Shares Bought

0

Total Shares Sold

167,206

ETON Price Chart
Loading chart...
DateTypeValue
Aug 24, 2026 Sell$1.63M
May 27, 2026 Sell$3.23M
Jan 12, 2026 Sell$30.3K
Dec 11, 2025 Sell$106.5K
Jun 12, 2025 Sell$504.3K